Would you like to participate ask a question join the surfers in our next episode?

S2-E25.2 – Prevalence of NAFLD and NASH 2021 — Deeper Dive

Louise Campbell and Roger Green join co-authors Stephen Harrison, Naim Alkhouri and first-time guest Prof. Samer Gawrieh in a deeper dive into key findings from the 2021 Journal of Hepatology paper titled "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort."

A deeper dive into the data coming from the 2021 Journal of Hepatology paper “Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort” reveals several troubling trends, including percentages of patients with F2/F3 NASH increasing far faster than the overall NAFLD rate and population subgroups where a majority of the patients in this study exhibited NAFLD and over 1/3 exhibited NASH. Whether you are familiar with the paper or not, you will want to listen to this conversation to hear points you might have missed.

TOPICS: AASLD, COVID-19, Diabetes, Diagnostic Tests, EchoSens, education, Fibrosis Level 3, Lean NASH, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Obesity, Perspectum Diagnostics, population screening, social policy, Fibrosis Level 2, Epidemiology, San Antonia Military Medical Center,

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast

Request Transcript of This Episode
Request Transcript
First
Last

NASH & Diabetes Podcast and NASH Tsunami Podcast